The US Food and Drug Administration is moving to establish additional premarket requirements for infusion pumps, as part of its new initiative to address safety problems associated with the devices1.
The agency has issued for comment draft guidance recommending that infusion pump manufacturers begin to provide additional design and engineering information to the agency during premarket review of the devices2...
Please login to read the full article.
